Adaptive Biotechnologies (ADPT) Capital Leases (2019)
Adaptive Biotechnologies (ADPT) posted Capital Leases of $36.6 million for Q4 2019, up 56.11% sequentially from $23.4 million in Q3 2019.
Adaptive Biotechnologies (ADPT) Capital Leases (2019) Analysis & Trends
Adaptive Biotechnologies (ADPT) has 1 years of Capital Leases data on file, last reported at $36.6 million in Q4 2019.
- Quarterly Capital Leases changed N/A year-over-year to $36.6 million in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $36.6 million (changed N/A YoY) and the FY2019 annual result came in at $36.6 million, changed N/A from the prior year.
- Capital Leases rose to $36.6 million in Q4 2019 per ADPT's latest filing, from $23.4 million in the prior quarter.
- The five-year high for Capital Leases was $36.6 million in Q4 2019, with the low at $23.4 million in Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn |
| 10 | Adaptive Biotechnologies | 3.48 Bn | 3.27 Bn | 52.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 36.61 Mn |
| Sep 30, 2019 | 23.45 Mn |